Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice

Selective serotonin reuptake inhibitors and inflammatory bowel disease; Beneficial or malpractice

IBD, a chronic inflammatory disease, has been manifested as a growing health problem. No Crohn’s and Colitis councils have officially ratified anti-depressants as a routine regimen for IBD patients. However, some physicians empirically prescribe them to rectify functional bowel consequences such as...

Full description

Bibliographic Details
Main Authors: Mohammad Reza Hatamnejad, Shaghayegh Baradaran Ghavami, Marzieh Shirvani, Mona Asghari Ahmadabad, Shabnam Shahrokh, Maryam Farmani, Ghazal Sherkat, Hamid Asadzadeh Aghdaei, Mohammad Reza Zali
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-10-01
Series:Frontiers in Immunology
Subjects:
inflammatory bowel diseases
serotonin uptake inhibitors
pro-inflammatory
anti-inflammatory
Crohn’s disease
ulcerative colitis
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.980189/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.980189/full

Similar Items